Calvetti, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 120
AS - Asia 85
EU - Europa 81
SA - Sud America 6
AF - Africa 2
Totale 294
Nazione #
US - Stati Uniti d'America 120
SG - Singapore 36
CN - Cina 30
GB - Regno Unito 28
HK - Hong Kong 14
RU - Federazione Russa 13
IT - Italia 9
SE - Svezia 8
BR - Brasile 6
IE - Irlanda 6
FI - Finlandia 4
FR - Francia 4
KR - Corea 4
NL - Olanda 4
DE - Germania 3
TG - Togo 2
PT - Portogallo 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 294
Città #
Chandler 28
Southend 27
Singapore 23
Woodbridge 20
Hong Kong 14
Ashburn 13
New York 10
The Dalles 10
Beijing 6
Dublin 6
Nanjing 3
Washington 3
Jinan 2
Lawrence 2
Lomé 2
Marostica 2
Princeton 2
Seoul 2
Shenyang 2
Turku 2
Wilmington 2
Belo Horizonte 1
Camden 1
Clarksburg 1
Cleveland 1
Council Bluffs 1
Fortaleza 1
Frankfurt am Main 1
Fuzhou 1
Haikou 1
Ituiutaba 1
Kent 1
Ningbo 1
Saint Louis 1
Salvador 1
San Mateo 1
Santa Bárbara d'Oeste 1
Schertz 1
Shanghai 1
São João do Ivaí 1
Taizhou 1
Tashkent 1
Tianjin 1
Verona 1
Yicheng 1
Totale 205
Nome #
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 114
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 84
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 42
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG 32
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 28
Totale 300
Categoria #
all - tutte 1.383
article - articoli 1.383
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20216 2 2 0 1 0 0 0 0 0 0 1 0
2021/202221 3 9 0 3 1 0 0 0 0 0 0 5
2022/202352 2 6 2 20 3 8 0 2 2 0 4 3
2023/202449 0 5 8 6 9 15 0 2 0 2 2 0
2024/2025116 6 2 4 30 2 7 5 4 20 16 8 12
Totale 300